In outpatients with COVID-19 during Omicron variant circulation, molnupiravir and nirmatrelvir-ritonavir improved outcomes

Ann Intern Med. 2024 Jan 2. doi: 10.7326/J23-0108. Online ahead of print.ABSTRACTSommer I, Ledinger D, Thaler K, et al. Outpatient treatment of confirmed COVID-19: a living, rapid evidence review for the American College of Physicians (version 2). Ann Intern Med. 2023;176:1377-1385. 37722115.PMID:38163374 | DOI:10.7326/J23-0108

Source: Annals of Internal Medicine - January 1, 2024 Category: Internal Medicine Authors: Zain Chagla Source Type: research